585 related articles for article (PubMed ID: 24423237)
21. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
22. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
Cadogan CA; Ryder SA
Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
[TBL] [Abstract][Full Text] [Related]
23. Pharmacists' awareness of Australia's health care reforms and their beliefs and attitudes about their current and future roles.
Mak VS; Clark A; Poulsen JH; Udengaard KU; Gilbert AL
Int J Pharm Pract; 2012 Feb; 20(1):33-40. PubMed ID: 22236178
[TBL] [Abstract][Full Text] [Related]
24. Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views.
Butt F; Ream E
Int J Pharm Pract; 2016 May; 24(3):149-59. PubMed ID: 26671523
[TBL] [Abstract][Full Text] [Related]
25. Views and experiences of community pharmacy team members on antimicrobial stewardship activities in Scotland: a qualitative study.
Tonna AP; Weidmann AE; Sneddon J; Stewart D
Int J Clin Pharm; 2020 Oct; 42(5):1261-1269. PubMed ID: 32803554
[TBL] [Abstract][Full Text] [Related]
26. What do community pharmacists do?: results from a work sampling study in London.
Davies JE; Barber N; Taylor D
Int J Pharm Pract; 2014 Oct; 22(5):309-18. PubMed ID: 24423212
[TBL] [Abstract][Full Text] [Related]
27. Exploring the supply of non-prescription medicines from community pharmacies in Scotland.
Watson MC; Hart J; Johnston M; Bond CM
Pharm World Sci; 2008 Oct; 30(5):526-35. PubMed ID: 18297410
[TBL] [Abstract][Full Text] [Related]
28. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
[TBL] [Abstract][Full Text] [Related]
29. Quality improvement of community pharmacy services: a prioritisation exercise.
Newlands RS; Power A; Young L; Watson M
Int J Pharm Pract; 2018 Feb; 26(1):39-48. PubMed ID: 28349646
[TBL] [Abstract][Full Text] [Related]
30. Over-the-counter prescribing and pharmacists' adoption of new medicines: diffusion of innovations.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2013; 9(3):251-62. PubMed ID: 22835710
[TBL] [Abstract][Full Text] [Related]
31. Influence of pharmacy practice on community pharmacists' integration of medication and lab value information from electronic health records.
Hughes CA; Guirguis LM; Wong T; Ng K; Ing L; Fisher K
J Am Pharm Assoc (2003); 2011; 51(5):591-8. PubMed ID: 21896456
[TBL] [Abstract][Full Text] [Related]
32. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
[TBL] [Abstract][Full Text] [Related]
33. Community pharmacists' perceptions of services that benefit older people in New Zealand.
Tordoff J; Chang SY; Norris PT
Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
[TBL] [Abstract][Full Text] [Related]
34. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
Sim TF; Hattingh HL; Sherriff J; Tee LBG
Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
[TBL] [Abstract][Full Text] [Related]
35. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
Hanes CA; Wong KK; Saini B
Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
[TBL] [Abstract][Full Text] [Related]
36. Medication supply and management in rural Queensland: views of key informants in health service provision.
Tan AC; Emmerton L; Hattingh L; Jarvis V
Res Social Adm Pharm; 2012; 8(5):420-32. PubMed ID: 22222342
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a pharmacist-led, medicines education program for Aboriginal Health Workers.
McRae M; Taylor SJ; Swain L; Sheldrake C
Rural Remote Health; 2008; 8(4):946. PubMed ID: 19093711
[TBL] [Abstract][Full Text] [Related]
38. Existing arrangements for monitoring community pharmacies in England: can they have a role in the revalidation of pharmacists?
Jacobs S; Schafheutle EI; Jee SD; Elvey R; Hassell K; Noyce PR
Res Social Adm Pharm; 2013; 9(2):166-77. PubMed ID: 23517658
[TBL] [Abstract][Full Text] [Related]
39. Qualitative study using interviews and focus groups to explore the current and potential for antimicrobial stewardship in community pharmacy informed by the Theoretical Domains Framework.
Jones LF; Owens R; Sallis A; Ashiru-Oredope D; Thornley T; Francis NA; Butler C; McNulty CAM
BMJ Open; 2018 Dec; 8(12):e025101. PubMed ID: 30593557
[TBL] [Abstract][Full Text] [Related]
40. The introduction of the national e-health record into Australian community pharmacy practice: pharmacists' perceptions.
Mooranian A; Emmerton L; Hattingh L
Int J Pharm Pract; 2013 Dec; 21(6):405-12. PubMed ID: 23560554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
